$22.95
2.75% (Daily)
Market Cap
$2.75B
Revenue
$1.02B
Rank by MCap
#818
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Cedric Francois M.D., Ph.D.
Headquarters
Waltham, MA
Employees
705
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.
Loading chart…